The global biologics fill and finish services market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for biologics in various therapeutic areas such as oncology, immunology, and neurology. Biologics are also being used in combination with other therapies such as chemotherapy or radiation therapy for cancer treatment. The increasing number of clinical trials for new drugs is also driving the growth of this market. Liquid biologics fill and finish services accounted for the largest share in 2018 owing to their higher demand in clinical manufacturing applications due to their ease of use and lower cost compared with lyophilized products. Liquid biologics are preferred over lyophilized products because they can be stored at room temperature without refrigeration or freezing which makes them more convenient than lyophilized products which require cold storage facilities that need constant monitoring by trained personnel.
Some Of The Growth Factors Of This Market:
- Biologics Fill and Finish Services market growth is driven by the increasing demand for biologics in the pharmaceutical industry.
- The increasing number of biologics being approved by regulatory authorities is also a factor that drives the growth of this market.
- The growing number of mergers and acquisitions in the pharmaceutical industry is also a factor that drives this market's growth as it leads to increased demand for fill and finish services from these companies.
- Increasing research and development activities in biopharmaceuticals are also driving this market's growth as they lead to an increase in demand for fill and finish services from these companies, which are used to produce final dosage forms such as tablets, capsules, injectables, inhalers etc, from bulk drug substances or active pharmaceutical ingredients (APIs).
- Increasing prevalence of chronic diseases such as cancer, diabetes mellitus type 2 etc, is another factor that drives this market's growth because it leads to an increase in demand for biologics which are used to treat these diseases.
Industry Growth Insights published a new data on “Biologics Fill and Finish Services Market”. The research report is titled “Biologics Fill and Finish Services Market research by Types (Liquid, Lyophilized), By Applications (Clinical Manufacturing, Commercial Manufacturing, Others), By Players/Companies Boehringer Ingelheim, Cambrex, Novasep, Vetter, Lonza, Emergent BioSolutions, Cobra Biologics, Catalent, MabPlex, Polpharma Biologics, Baxter Healthcare Corporation, ABL, Inc., Rentschler Fill Solutions, Symbiosis Pharmaceutical Services, iBio”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biologics Fill and Finish Services Market Research Report
By Type
Liquid, Lyophilized
By Application
Clinical Manufacturing, Commercial Manufacturing, Others
By Companies
Boehringer Ingelheim, Cambrex, Novasep, Vetter, Lonza, Emergent BioSolutions, Cobra Biologics, Catalent, MabPlex, Polpharma Biologics, Baxter Healthcare Corporation, ABL, Inc., Rentschler Fill Solutions, Symbiosis Pharmaceutical Services, iBio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Biologics Fill and Finish Services Market Report Segments:
The global Biologics Fill and Finish Services market is segmented on the basis of:
Types
Liquid, Lyophilized
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Manufacturing, Commercial Manufacturing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Cambrex
- Novasep
- Vetter
- Lonza
- Emergent BioSolutions
- Cobra Biologics
- Catalent
- MabPlex
- Polpharma Biologics
- Baxter Healthcare Corporation
- ABL, Inc.
- Rentschler Fill Solutions
- Symbiosis Pharmaceutical Services
- iBio
Highlights of The Biologics Fill and Finish Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid
- Lyophilized
- By Application:
- Clinical Manufacturing
- Commercial Manufacturing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biologics Fill and Finish Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biologics Fill and Finish Services is a process that helps pharmaceutical companies to complete the final steps of the drug development process, including manufacturing and marketing.
Some of the major players in the biologics fill and finish services market are Boehringer Ingelheim, Cambrex, Novasep, Vetter, Lonza, Emergent BioSolutions, Cobra Biologics, Catalent, MabPlex, Polpharma Biologics, Baxter Healthcare Corporation, ABL, Inc., Rentschler Fill Solutions, Symbiosis Pharmaceutical Services, iBio.
The biologics fill and finish services market is expected to register a CAGR of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biologics Fill and Finish Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biologics Fill and Finish Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biologics Fill and Finish Services Market - Supply Chain
4.5. Global Biologics Fill and Finish Services Market Forecast
4.5.1. Biologics Fill and Finish Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biologics Fill and Finish Services Market Size (000 Units) and Y-o-Y Growth
4.5.3. Biologics Fill and Finish Services Market Absolute $ Opportunity
5. Global Biologics Fill and Finish Services Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Type
5.3.1. Liquid
5.3.2. Lyophilized
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Biologics Fill and Finish Services Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Application
6.3.1. Clinical Manufacturing
6.3.2. Commercial Manufacturing
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Biologics Fill and Finish Services Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Biologics Fill and Finish Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Biologics Fill and Finish Services Demand Share Forecast, 2019-2026
9. North America Biologics Fill and Finish Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Biologics Fill and Finish Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Biologics Fill and Finish Services Market Size and Volume Forecast by Application
9.4.1. Clinical Manufacturing
9.4.2. Commercial Manufacturing
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Biologics Fill and Finish Services Market Size and Volume Forecast by Type
9.7.1. Liquid
9.7.2. Lyophilized
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Biologics Fill and Finish Services Demand Share Forecast, 2019-2026
10. Latin America Biologics Fill and Finish Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Biologics Fill and Finish Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Biologics Fill and Finish Services Market Size and Volume Forecast by Application
10.4.1. Clinical Manufacturing
10.4.2. Commercial Manufacturing
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Biologics Fill and Finish Services Market Size and Volume Forecast by Type
10.7.1. Liquid
10.7.2. Lyophilized
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Biologics Fill and Finish Services Demand Share Forecast, 2019-2026
11. Europe Biologics Fill and Finish Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Biologics Fill and Finish Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Biologics Fill and Finish Services Market Size and Volume Forecast by Application
11.4.1. Clinical Manufacturing
11.4.2. Commercial Manufacturing
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Biologics Fill and Finish Services Market Size and Volume Forecast by Type
11.7.1. Liquid
11.7.2. Lyophilized
11.8 Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Biologics Fill and Finish Services Demand Share, 2019-2026
12. Asia Pacific Biologics Fill and Finish Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Biologics Fill and Finish Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Biologics Fill and Finish Services Market Size and Volume Forecast by Application
12.4.1. Clinical Manufacturing
12.4.2. Commercial Manufacturing
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Biologics Fill and Finish Services Market Size and Volume Forecast by Type
12.7.1. Liquid
12.7.2. Lyophilized
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Biologics Fill and Finish Services Demand Share, 2019-2026
13. Middle East & Africa Biologics Fill and Finish Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Biologics Fill and Finish Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Biologics Fill and Finish Services Market Size and Volume Forecast by Application
13.4.1. Clinical Manufacturing
13.4.2. Commercial Manufacturing
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Biologics Fill and Finish Services Market Size and Volume Forecast by Type
13.7.1. Liquid
13.7.2. Lyophilized
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Biologics Fill and Finish Services Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Biologics Fill and Finish Services Market: Market Share Analysis
14.2. Biologics Fill and Finish Services Distributors and Customers
14.3. Biologics Fill and Finish Services Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cambrex
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novasep
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Vetter
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lonza
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Emergent BioSolutions
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cobra Biologics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Catalent
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. MabPlex
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Polpharma Biologics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Baxter Healthcare Corporation
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. ABL, Inc.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Rentschler Fill Solutions
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Symbiosis Pharmaceutical Services
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. iBio
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook